News
-
July 9th 2020 - Press notes
Dr. Arnau Busquets, currently a Ramon y Cajal researcher in the IMIM's Integrated Pharmacology and Systems Neuroscience Research Group is one of the first authors of this work.
more information
-
June 30th 2020 - Press notes
The successful projects are "Obtaining antioxidant active substances from the carob pod and validating their therapeutic potential", which involves the company Euronutra, the IBIMA (Malaga Biomedical Research Institute), the IMIM (Hospital del Mar Medical Research Institute), and the CRG (Centre for Genomic Regulation); and the project "Development of a new therapy for Fragile X syndrome", in which the company Connecta Therapeutics, the IMIM, and the CRG are participating.
more information
-
June 3rd 2020 - Press release
This is a pioneering Data Analytics project in Spain, which will enable us to increase our knowledge of the evolution of COVID-19 and its interaction with patients with other pathologies based on the analysis of discharge reports. The initiative is the result of collaboration between Hospital del Mar, the technology company Bismart and Ferrer Laboratory and uses the artificial intelligence tool Bismart Folksonomy. In less than a month, a project has been launched with more than 34,000 hospital and emergency room discharges, 2,700 of which correspond to COVID-19 patients. This will allow an in-depth analysis of their evolution and the relationship of the infection with other basic pathologies.
more information
-
May 28th 2020 - Press notes
The MINDUP project began in January 2020 to support SMEs in the mental health care of their workers. Now adapting to the COVID-19 pandemic and highlighting its usefulness in current circumstances.
more information
-
May 25th 2020 - Press notes
The company Chemotargets -based in the Barcelona Science Park and a leader in in the global market as a provider of intelligence and drug design prediction platform- has signed a strategic agreement with the Hospital del Mar Medical Research Institute (IMIM) to discovery and development of new oncological therapies that respond to important unmet medical needs.
more information
-
4th May, 2020 - Press notes
This is the first time that anyone has studied how brain alterations at a functional level in mice with Down syndrome respond to chronic treatment with a component of green tea that we know, from other studies, improves executive functions in adults with Down syndrome.
more information
-
March 9th 2020 - Press release
Researchers at the Hospital del Mar Institute for Medical Research have led a study demonstrating how the relationship between two molecules plays a key role in the generation of these cells. The work has been published in The EMBO Journal.
more information
-
February 14th 2020 - Press release
A joint study between Hospital del Mar, IDIBELL, the University of Helsinki and the Spanish National Research Council funded by La Marató de TV3 tries to analyze the effects of music therapy (musical learning) once patients have finished hospital rehabilitation and are in a chronic state of the disease. To do this, they designed a keyboard linked to a smart tablet that allows the participants of the study to do their exercises at home and learn gradually in an established manner. An earlier study of the same group shows that musical therapy, like other therapies, has similar effects in motor rehabilitation for patients who have suffered a stroke, having a strong impact in mood improvement and quality of life.
more information
-
February 6th 2020 - Press notes
The company, founded today, is backed by IMIM and UPF and is developing products and services based on the DisGeNET platform, one of the tools on the genetics of diseases with most information in the world.
more information
-
December 13th - Press release
Researchers led by Dr. Consol Serra have studied the exact, individualized cost of patients suffering from occupational diseases admitted to Hospital del Mar.
more information